Looks like pharma inflation is back on the menu

Author: Adam Button | Category: News

Amazon shelves plans to get into the drug business

CNBC is reporting that Amazon has put its plans to sell pharmaceuticals on hold.

That's giving a lift to any company in that line of business.

In the longer-term, it's also a bit more inflationary (or less deflationary) than it would have been if Amazon went into the business. The Fed might think that's a good thing, but I don't think consumers fell the same way.

By continuing to browse our site you agree to our use of cookies, revised Privacy Notice and Terms of Service. More information about cookies